Valuation dashboard for Rocket Pharmaceuticals, Inc. (RCKT) with P/E N/A, P/B 1.02, EV/EBITDA 20.89 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Rocket Pharmaceuticals, Inc., operating alongside its affiliates, is an innovative biotechnology enterprise dedicated to pioneering gene therapies for rare and severely debilitating diseases. The company's active clinical pipeline features multiple promising programs.
Analysis Summary
Trailing-twelve-month margins: gross margin 0.0%, operating margin 0.0%, net margin 0.0%.
At the current price of $3.48, RCKT has negative trailing earnings (P/E not meaningful) and an ROE of -5.76%. Market capitalisation stands at $380M.
Balance sheet quality for RCKT: current ratio of 6.4. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 1.02 |
| EV / EBITDA | 20.89 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $0.47 |
| vs Current Price | -86.4% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| RCKT | Rocket Pharmaceuticals, Inc. | $380M | 1.02 | -5.8% | |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.6B | 29.76 | 6.46 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $3.48 |
| Market Cap | $380M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -5.76% |
| Return on Invested Capital | -48.55% |
| Return on Assets | -4.08% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: ANNX · AURA · AUTL · DBVT · DSGN · GALT · IMAB
Explore sector: Healthcare · Biotechnology
More sections of RCKT: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks